{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:15:59Z","timestamp":1794960959464,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KO6815\/1-11"],"award-info":[{"award-number":["KO6815\/1-11"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HE2526\/9-2"],"award-info":[{"award-number":["HE2526\/9-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["3P01AI129859-04S1"],"award-info":[{"award-number":["3P01AI129859-04S1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["3P01AI129859"],"award-info":[{"award-number":["3P01AI129859"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32-CA009111"],"award-info":[{"award-number":["T32-CA009111"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["2TL1-TR-2386"],"award-info":[{"award-number":["2TL1-TR-2386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P51OD011092"],"award-info":[{"award-number":["P51OD011092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["OD016261"],"award-info":[{"award-number":["OD016261"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P51-OD011107"],"award-info":[{"award-number":["P51-OD011107"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002553"],"award-info":[{"award-number":["UL1TR002553"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"U.S. Department of Health & Human Services | NIH | National Center for Research Resources","doi-asserted-by":"publisher","award":["OD011104"],"award-info":[{"award-number":["OD011104"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["DP2HD075699"],"award-info":[{"award-number":["DP2HD075699"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human cytomegalovirus (HCMV) encodes four viral Fc-gamma receptors (vFc\u03b3Rs) that counteract antibody-mediated activation in vitro, but their role in infection and pathogenesis is unknown. To examine their in vivo function in an animal model evolutionarily closely related to humans, we identified and characterized Rh05, Rh152\/151 and Rh173 as the complete set of vFc\u03b3Rs encoded by rhesus CMV (RhCMV). Each one of these proteins displays functional similarities to their prospective HCMV orthologs with respect to antagonizing host Fc\u03b3R activation in vitro. When RhCMV-na\u00efve male rhesus macaques were infected with vFc\u03b3R-deleted RhCMV, peak plasma DNAemia levels and anti-RhCMV antibody responses were comparable to wildtype infections of both male and female animals. However, the duration of plasma DNAemia was significantly shortened in immunocompetent, but not in CD4\u2009+\u2009T cell-depleted animals. Since vFc\u03b3Rs were not required for superinfection of rhesus macaques, we conclude that these proteins can prolong lytic replication during primary infection by evading virus-specific adaptive immune responses, particularly antibodies.<\/jats:p>","DOI":"10.1038\/s41467-025-56419-3","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T20:43:37Z","timestamp":1738269817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Rhesus Cytomegalovirus-encoded Fc\u03b3-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunity"],"prefix":"10.1038","volume":"16","author":[{"given":"Claire E.","family":"Otero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Petkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1621-177X","authenticated-orcid":false,"given":"Martin","family":"Ebermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nessy","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3749-9047","authenticated-orcid":false,"given":"Katja","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Davalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7261-6638","authenticated-orcid":false,"given":"Matilda J.","family":"Mostr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne M.","family":"Gilbride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney R.","family":"Papen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Barber-Axthelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Scheef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Barfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesli M.","family":"Sprehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savannah","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabitha D.","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Beechwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh Khanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan H.","family":"Vande Burgt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliburn","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary J.","family":"Streblow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel N.","family":"Streblow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice F.","family":"Tarantal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie","family":"Permar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8014-3877","authenticated-orcid":false,"given":"Klaus","family":"Fr\u00fch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3482-816X","authenticated-orcid":false,"given":"Hartmut","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1287-7283","authenticated-orcid":false,"given":"Daniel","family":"Malouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7935-217X","authenticated-orcid":false,"given":"Philipp","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"56419_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00705-008-0278-4","volume":"154","author":"AJ Davison","year":"2009","unstructured":"Davison, A. J. et al. The order Herpesvirales. Arch. Virol. 154, 171\u2013177 (2009).","journal-title":"Arch. Virol."},{"key":"56419_CR2","doi-asserted-by":"publisher","first-page":"e1008666","DOI":"10.1371\/journal.ppat.1008666","volume":"16","author":"H Taher","year":"2020","unstructured":"Taher, H. et al. In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genome. PLoS Pathog. 16, e1008666 (2020).","journal-title":"PLoS Pathog."},{"key":"56419_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fcimb.2020.00130","volume":"10","author":"E Forte","year":"2020","unstructured":"Forte, E., Zhang, Z., Thorp, E. B. & Hummel, M. Cytomegalovirus latency and reactivation: An intricate interplay with the host immune response. Front. Cell. Infect. Microbiol. 10, 130 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"56419_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1084\/jem.20050882","volume":"202","author":"AW Sylwester","year":"2005","unstructured":"Sylwester, A. W. et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202, 673\u2013685 (2005).","journal-title":"J. Exp. Med."},{"key":"56419_CR5","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","volume":"21","author":"K Takenaka","year":"2015","unstructured":"Takenaka, K. et al. Cytomegalovirus reactivation after sllogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid Leukemia who survived to day 100 after transplantation: The Japan society for hematopoietic cell transplantation transplantation-related complication working group. Biol. Blood Marrow Transpl. 21, 2008\u20132016 (2015).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"56419_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/rmv.544","volume":"17","author":"SC Dollard","year":"2007","unstructured":"Dollard, S. C., Grosse, S. D. & Ross, D. S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 17, 355\u2013363 (2007).","journal-title":"Rev. Med. Virol."},{"key":"56419_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1128\/CMR.00023-08","volume":"22","author":"MC Cheeran","year":"2009","unstructured":"Cheeran, M. C., Lokensgard, J. R. & Schleiss, M. R. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin. Microbiol. Rev. 22, 99\u2013126 (2009).","journal-title":"Clin. Microbiol. Rev."},{"key":"56419_CR8","unstructured":"Stratton, K.R., Durch, J.S., Lawrence, R.S. Vaccines for the 21st Century: A Tool for Decisionmaking. (2000)."},{"key":"56419_CR9","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","volume":"377","author":"PD Griffiths","year":"2011","unstructured":"Griffiths, P. D. et al. Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet 377, 1256\u20131263 (2011).","journal-title":"Lancet"},{"key":"56419_CR10","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","volume":"360","author":"RF Pass","year":"2009","unstructured":"Pass, R. F. et al. Vaccine prevention of maternal cytomegalovirus infection. N. Engl. J. Med. 360, 1191\u20131199 (2009).","journal-title":"N. Engl. J. Med."},{"key":"56419_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","volume":"34","author":"DI Bernstein","year":"2016","unstructured":"Bernstein, D. I. et al. Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial. Vaccine 34, 313\u2013319 (2016).","journal-title":"Vaccine"},{"key":"56419_CR12","doi-asserted-by":"publisher","first-page":"13645","DOI":"10.1073\/pnas.1511526112","volume":"112","author":"KM Bialas","year":"2015","unstructured":"Bialas, K. M. et al. Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission. Proc. Natl. Acad. Sci. USA 112, 13645\u201313650 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"56419_CR13","doi-asserted-by":"publisher","first-page":"e94002","DOI":"10.1172\/jci.insight.94002","volume":"2","author":"CS Nelson","year":"2017","unstructured":"Nelson, C. S. et al. Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys. JCI Insight 2, e94002 (2017).","journal-title":"JCI Insight"},{"key":"56419_CR14","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1056\/NEJMc2114296","volume":"386","author":"G Nigro","year":"2022","unstructured":"Nigro, G. Hyperimmune globulin for congenital cytomegalovirus infection. N. Engl. J. Med. 386, 1002\u20131003 (2022).","journal-title":"N. Engl. J. Med."},{"key":"56419_CR15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/uog.23596","volume":"57","author":"KO Kagan","year":"2021","unstructured":"Kagan, K. O. et al. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study. Ultrasound Obstet. Gynecol. 57, 560\u2013567 (2021).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"56419_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJMoa1913569","volume":"385","author":"BL Hughes","year":"2021","unstructured":"Hughes, B. L. et al. A trial of hyperimmune globulin to prevent congenital cytomegalovirus infection. N. Engl. J. Med. 385, 436\u2013444 (2021).","journal-title":"N. Engl. J. Med."},{"key":"56419_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/14767058.2017.1387890","volume":"32","author":"D Blazquez-Gamero","year":"2019","unstructured":"Blazquez-Gamero, D. et al. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid. J. Matern. Fetal Neonatal Med. 32, 617\u2013625 (2019).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"56419_CR18","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","volume":"370","author":"MG Revello","year":"2014","unstructured":"Revello, M. G. et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N. Engl. J. Med. 370, 1316\u20131326 (2014).","journal-title":"N. Engl. J. Med."},{"key":"56419_CR19","doi-asserted-by":"publisher","unstructured":"Semmes, E. C. et al. Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection. J. Clin. Invest. 132, https:\/\/doi.org\/10.1172\/jci156827 (2022).","DOI":"10.1172\/jci156827"},{"key":"56419_CR20","doi-asserted-by":"crossref","unstructured":"Semmes, E. C. et al. ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection. JCI Insight 8, e167768 (2023)","DOI":"10.1172\/jci.insight.167768"},{"key":"56419_CR21","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/jvi.61.7.2208-2216.1987","volume":"61","author":"DC Johnson","year":"1987","unstructured":"Johnson, D. C. & Feenstra, V. Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. J. Virol. 61, 2208\u20132216 (1987).","journal-title":"J. Virol."},{"key":"56419_CR22","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1128\/jvi.63.11.4479-4488.1989","volume":"63","author":"I Frank","year":"1989","unstructured":"Frank, I. & Friedman, H. M. A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J. Virol. 63, 4479\u20134488 (1989).","journal-title":"J. Virol."},{"key":"56419_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1128\/jvi.32.3.779-789.1979","volume":"32","author":"RB Baucke","year":"1979","unstructured":"Baucke, R. B. & Spear, P. G. Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J. Virol. 32, 779\u2013789 (1979).","journal-title":"J. Virol."},{"key":"56419_CR24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1128\/iai.26.2.770-774.1979","volume":"26","author":"M Ogata","year":"1979","unstructured":"Ogata, M. & Shigeta, S. Appearance of immunoglobulin G Fc receptor in cultured human cells infected with varicella-zoster virus. Infect. Immun. 26, 770\u2013774 (1979).","journal-title":"Infect. Immun."},{"key":"56419_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0042-6822(87)90157-7","volume":"161","author":"CM Edson","year":"1987","unstructured":"Edson, C. M., Hosler, B. A. & Waters, D. J. Varicella-zoster virus gpI and herpes simplex virus gE: phosphorylation and Fc binding. Virology 161, 599\u2013602 (1987).","journal-title":"Virology"},{"key":"56419_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/BF02919129","volume":"11","author":"V Litwin","year":"1992","unstructured":"Litwin, V. & Grose, C. Herpesviral Fc receptors and their relationship to the human Fc receptors. Immunol. Res. 11, 226\u2013238 (1992).","journal-title":"Immunol. Res."},{"key":"56419_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/1348-0421.12867","volume":"65","author":"R Majima","year":"2021","unstructured":"Majima, R., Koshizuka, T. & Inoue, N. The Guinea pig cytomegalovirus GP119.1 gene encodes an IgG-binding glycoprotein that is incorporated into the virion. Microbiol. Immunol. 65, 28\u201339 (2021).","journal-title":"Microbiol. Immunol."},{"key":"56419_CR28","doi-asserted-by":"publisher","first-page":"e02077","DOI":"10.1128\/JVI.02077-18","volume":"93","author":"P Kolb","year":"2019","unstructured":"Kolb, P. et al. Identification and functional characterization of a novel Fc gamma-binding glycoprotein in rhesus cytomegalovirus. J. Virol. 93, e02077\u201318 (2019).","journal-title":"J. Virol."},{"key":"56419_CR29","doi-asserted-by":"publisher","first-page":"8596","DOI":"10.1128\/JVI.76.17.8596-8608.2002","volume":"76","author":"R Atalay","year":"2002","unstructured":"Atalay, R. et al. Identification and expression of human cytomegalovirus transcription units coding for two distinct Fc receptor homologs. J. Virol. 76, 8596\u20138608 (2002).","journal-title":"J. Virol."},{"key":"56419_CR30","doi-asserted-by":"publisher","first-page":"11218","DOI":"10.1128\/JVI.75.22.11218-11221.2001","volume":"75","author":"BN Lilley","year":"2001","unstructured":"Lilley, B. N., Ploegh, H. L. & Tirabassi, R. S. Human cytomegalovirus open reading frame TRL11\/IRL11 encodes an immunoglobulin G Fc-binding protein. J. Virol. 75, 11218\u201311221 (2001).","journal-title":"J. Virol."},{"key":"56419_CR31","doi-asserted-by":"publisher","first-page":"7757","DOI":"10.1128\/jvi.68.12.7757-7765.1994","volume":"68","author":"R Thale","year":"1994","unstructured":"Thale, R., Lucin, P., Schneider, K., Eggers, M. & Koszinowski, U. H. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J. Virol. 68, 7757\u20137765 (1994).","journal-title":"J. Virol."},{"key":"56419_CR32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1128\/jcm.2.4.332-336.1975","volume":"2","author":"T Furukawa","year":"1975","unstructured":"Furukawa, T., Hornberger, E., Sakuma, S. & Plotkin, S. A. Demonstration of immunoglobulin G receptors induced by human cytomegalovirus. J. Clin. Microbiol. 2, 332\u2013336 (1975).","journal-title":"J. Clin. Microbiol."},{"key":"56419_CR33","doi-asserted-by":"publisher","first-page":"e50166","DOI":"10.1371\/journal.pone.0050166","volume":"7","author":"M Cortese","year":"2012","unstructured":"Cortese, M., Calo, S., D\u2019Aurizio, R., Lilja, A., Pacchiani, N. & Merola M. Recombinant human cytomegalovirus (HCMV) RL13 binds human immunoglobulin G Fc. PloS ONE 7, e50166 (2012).","journal-title":"PloS ONE"},{"key":"56419_CR34","doi-asserted-by":"publisher","first-page":"e63877","DOI":"10.7554\/eLife.63877","volume":"10","author":"P Kolb","year":"2021","unstructured":"Kolb, P. et al. Human Cytomegalovirus antagonizes activation of Fcgamma receptors by distinct and synergizing modes of IgG manipulation. Elife 10, e63877 (2021).","journal-title":"Elife"},{"key":"56419_CR35","doi-asserted-by":"publisher","first-page":"e1004131","DOI":"10.1371\/journal.ppat.1004131","volume":"10","author":"E Corrales-Aguilar","year":"2014","unstructured":"Corrales-Aguilar, E. et al. Human cytomegalovirus Fcgamma binding proteins gp34 and gp68 antagonize Fcgamma receptors I, II and III. PLoS Pathog. 10, e1004131 (2014).","journal-title":"PLoS Pathog."},{"key":"56419_CR36","doi-asserted-by":"publisher","first-page":"8959","DOI":"10.1128\/JVI.01132-12","volume":"86","author":"D Malouli","year":"2012","unstructured":"Malouli, D. et al. Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1. J. Virol. 86, 8959\u20138973 (2012).","journal-title":"J. Virol."},{"key":"56419_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02460-2","volume":"7","author":"Z Liu","year":"2017","unstructured":"Liu, Z. et al. Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector. Sci. Rep. 7, 2193 (2017).","journal-title":"Sci. Rep."},{"key":"56419_CR38","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1099\/vir.0.79888-0","volume":"85","author":"A Dolan","year":"2004","unstructured":"Dolan, A. et al. Genetic content of wild-type human cytomegalovirus. J. Gen. Virol. 85, 1301\u20131312 (2004).","journal-title":"J. Gen. Virol."},{"key":"56419_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jim.2012.09.006","volume":"387","author":"E Corrales-Aguilar","year":"2013","unstructured":"Corrales-Aguilar, E. et al. A novel assay for detecting virus-specific antibodies triggering activation of Fcgamma receptors. J. Immunol. Methods 387, 21\u201335 (2013).","journal-title":"J. Immunol. Methods"},{"key":"56419_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1126\/science.1185350","volume":"328","author":"SG Hansen","year":"2010","unstructured":"Hansen, S. G. et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 328, 102\u2013106 (2010).","journal-title":"Science"},{"key":"56419_CR41","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1099\/0022-1317-80-11-2867","volume":"80","author":"C Sinzger","year":"1999","unstructured":"Sinzger, C. et al. Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J. Gen. Virol. 80, 2867\u20132877 (1999).","journal-title":"J. Gen. Virol."},{"key":"56419_CR42","doi-asserted-by":"publisher","first-page":"eabg5413","DOI":"10.1126\/sciimmunol.abg5413","volume":"6","author":"D Malouli","year":"2021","unstructured":"Malouli, D. et al. Cytomegaloviral determinants of CD8(+) T cell programming and RhCMV\/SIV vaccine efficacy. Sci. Immunol. 6, eabg5413 (2021).","journal-title":"Sci. Immunol."},{"key":"56419_CR43","doi-asserted-by":"publisher","first-page":"e1006014","DOI":"10.1371\/journal.ppat.1006014","volume":"12","author":"BJ Burwitz","year":"2016","unstructured":"Burwitz, B. J. et al. Cross-species rhesus cytomegalovirus infection of cynomolgus macaques. PLoS Pathog. 12, e1006014 (2016).","journal-title":"PLoS Pathog."},{"key":"56419_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1106401","volume":"13","author":"G Vezzani","year":"2022","unstructured":"Vezzani, G. et al. Human immunoglobulins are transported to HCMV viral envelope by viral Fc gamma receptors-dependent and independent mechanisms. Front. Microbiol. 13, 1106401 (2022).","journal-title":"Front. Microbiol."},{"key":"56419_CR45","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.4049\/jimmunol.1502252","volume":"197","author":"YN Chan","year":"2016","unstructured":"Chan, Y. N. et al. IgG Binding characteristics of Rhesus Macaque FcyR. J. Immunol. 197, 2936\u20132947 (2016).","journal-title":"J. Immunol."},{"key":"56419_CR46","doi-asserted-by":"publisher","first-page":"e1005868","DOI":"10.1371\/journal.ppat.1005868","volume":"12","author":"ER Sturgill","year":"2016","unstructured":"Sturgill, E. R. et al. Natural killer cell evasion is essential for infection by Rhesus Cytomegalovirus. PLoS Pathog. 12, e1005868 (2016).","journal-title":"PLoS Pathog."},{"key":"56419_CR47","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1128\/JVI.72.2.1377-1382.1998","volume":"72","author":"MertensI Crnkovic-","year":"1998","unstructured":"Crnkovic-, MertensI. et al. Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J. Virol. 72, 1377\u20131382 (1998).","journal-title":"J. Virol."},{"key":"56419_CR48","doi-asserted-by":"publisher","first-page":"8422","DOI":"10.4049\/jimmunol.177.12.8422","volume":"177","author":"JD Mintern","year":"2006","unstructured":"Mintern, J. D. et al. Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J. Immunol. 177, 8422\u20138431 (2006).","journal-title":"J. Immunol."},{"key":"56419_CR49","doi-asserted-by":"publisher","first-page":"e59350","DOI":"10.7554\/eLife.59350","volume":"10","author":"G Angulo","year":"2021","unstructured":"Angulo, G. et al. Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion. Elife 10, e59350 (2021).","journal-title":"Elife"},{"key":"56419_CR50","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1084\/jem.20060514","volume":"203","author":"T Lenac","year":"2006","unstructured":"Lenac, T. et al. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J. Exp. Med. 203, 1843\u20131850 (2006).","journal-title":"J. Exp. Med."},{"key":"56419_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.molimm.2009.02.010","volume":"47","author":"J Arapovic","year":"2009","unstructured":"Arapovic, J., Lenac Rovis, T., Reddy, A. B., Krmpotic, A. & Jonjic, S. Promiscuity of MCMV immunoevasin of NKG2D: m138\/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60. Mol. Immunol. 47, 114\u2013122 (2009).","journal-title":"Mol. Immunol."},{"key":"56419_CR52","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature10003","volume":"473","author":"SG Hansen","year":"2011","unstructured":"Hansen, S. G. et al. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473, 523\u2013527 (2011).","journal-title":"Nature"},{"key":"56419_CR53","doi-asserted-by":"publisher","first-page":"jem.20191164","DOI":"10.1084\/jem.20191164","volume":"217","author":"M Lubke","year":"2020","unstructured":"Lubke, M. et al. Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models. J. Exp. Med. 217, jem.20191164 (2020).","journal-title":"J. Exp. Med."},{"key":"56419_CR54","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1084\/jem.20020295","volume":"196","author":"JM den Haan","year":"2002","unstructured":"den Haan, J. M. & Bevan, M. J. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J. Exp. Med. 196, 817\u2013827 (2002).","journal-title":"J. Exp. Med."},{"key":"56419_CR55","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.1128\/JVI.00435-10","volume":"84","author":"K Morizono","year":"2010","unstructured":"Morizono, K. et al. Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins. J. Virol. 84, 6923\u20136934 (2010).","journal-title":"J. Virol."},{"key":"56419_CR56","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0166-0934(02)00060-5","volume":"104","author":"WL Chang","year":"2002","unstructured":"Chang, W. L., Kirchoff, V., Pari, G. S. & Barry, P. A. Replication of rhesus cytomegalovirus in life-expanded rhesus fibroblasts expressing human telomerase. J. Virol. Methods 104, 135\u2013146 (2002).","journal-title":"J. Virol. Methods"},{"key":"56419_CR57","doi-asserted-by":"publisher","first-page":"e1008040","DOI":"10.1371\/journal.ppat.1008040","volume":"15","author":"C Zimmermann","year":"2019","unstructured":"Zimmermann, C. et al. HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11. PLoS Pathog. 15, e1008040 (2019).","journal-title":"PLoS Pathog."},{"key":"56419_CR58","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3390\/v15041023","volume":"15","author":"A Ourahmane","year":"2023","unstructured":"Ourahmane, A., Hertel, L. & McVoy, M. A. The RL13 temperance factor represses replication of the highly cell culture-adapted towne strain of human cytomegalovirus. Viruses 15, 1023 (2023).","journal-title":"Viruses"},{"key":"56419_CR59","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1172\/JCI42955","volume":"120","author":"RJ Stanton","year":"2010","unstructured":"Stanton, R. J. et al. Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J. Clin. Invest. 120, 3191\u20133208 (2010).","journal-title":"J. Clin. Invest."},{"key":"56419_CR60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/978-1-60761-652-8_30","volume":"634","author":"BK Tischer","year":"2010","unstructured":"Tischer, B. K., Smith, G. A. & Osterrieder, N. En passant mutagenesis: a two step markerless red recombination system. Methods Mol. Biol. 634, 421\u2013430 (2010).","journal-title":"Methods Mol. Biol."},{"key":"56419_CR61","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1172\/JCI67420","volume":"124","author":"D Malouli","year":"2014","unstructured":"Malouli, D. et al. Cytomegalovirus pp65 limits dissemination but is dispensable for persistence. J. Clin. Invest. 124, 1928\u20131944 (2014).","journal-title":"J. Clin. Invest."},{"key":"56419_CR62","unstructured":"Council, N. R. Guide for the Care and Use of Laboratory Animals. 8th edn, (National Academies Press, 2011)."},{"key":"56419_CR63","unstructured":"Tarantal A. F. The Laboratory Primate (Chapter 20; 317-352). (Elsevier, 2005)."},{"key":"56419_CR64","doi-asserted-by":"publisher","first-page":"e1011378","DOI":"10.1371\/journal.ppat.1011378","volume":"19","author":"CE Otero","year":"2023","unstructured":"Otero, C. E. et al. Relationship of maternal cytomegalovirus-specific antibody responses and viral load to vertical transmission risk following primary maternal infection in a rhesus macaque model. PLoS Pathog. 19, e1011378 (2023).","journal-title":"PLoS Pathog."},{"key":"56419_CR65","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1198\/000313006X118430","volume":"60","author":"T Hothorn","year":"2006","unstructured":"Hothorn, T., Hornik, K., van de Wiel, M. A. & Zeileis, A. A Lego System for conditional inference. Am. Stat. 60, 257\u2013263 (2006).","journal-title":"Am. Stat."},{"key":"56419_CR66","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50, 163\u2013170 (1966).","journal-title":"Cancer Chemother. Rep."},{"key":"56419_CR67","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan, E. L. & Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457\u2013481 (1958).","journal-title":"J. Am. Stat. Assoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56419-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56419-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56419-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T20:43:42Z","timestamp":1738269822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56419-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56419"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56419-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.27.582371","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.R.P. has served as a consultant to Merck, Moderna, Pfizer, GSK and Dynavax and has led sponsored programs with Moderna and Merck. P.K. has received funding from Biotest AG. None of these activities have impacted this work. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1200"}}